Nectar Lifesciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
NECLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nectar Lifesciences Limited has informed the stock exchanges that the trading window for its designated persons and their immediate relatives will remain closed. The window stays shut until the declaration of audited financial results for the quarter and full year ended March 31, 2025, and will then remain closed again from July 1, 2025, until 48 hours after the declaration of unaudited results for the quarter ended June 30, 2025. This is a routine compliance update under SEBI's Prohibition of Insider Trading Regulations, 2015, and the company has not yet announced the board meeting date for these results. Designated persons and their relatives are barred from trading in the company's shares during this period.
This is a routine regulatory compliance announcement and does not have a direct impact on the stock price. It simply restricts insider trading ahead of upcoming financial results, which is standard practice for listed companies in India.